Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
L287351-5mg | 5mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $399.90 | |
L287351-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $99.90 | |
L287351-25mg | 25mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $999.90 | |
L287351-50mg | 50mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $422.90 |
HCA2(GPR109A) partial agonist
Synonyms | 5-Butyl-2H-pyrazole-3-carboxylic acid | BDBM50220842 | AKOS000301963 | LUF6283;LUF-6283 | BBL030719 | ZJTXSGLJNBAMJS-UHFFFAOYSA-N | 3-butyl-1H-pyrazole-5-carboxylicacid | VS-09994 | LUF 6283 | EN300-237993 | 1H-Pyrazole-3-carboxylic acid, 5-butyl- | SCHEM |
---|---|
Specifications & Purity | Moligand™, ≥98%(HPLC) |
Biochemical and Physiological Mechanisms | Partial agonist of hydroxycarboxylic acid receptor 2 (HCA2) (Ki= 0.55μM). Thought to lower plasma very-low-density lipoprotein (VLDL)-triglyceride levels by affecting hepatic VLDL production in normolipidemic C57BL/6 mice. |
Storage Temp | Store at 2-8°C |
Shipped In | Wet ice |
Grade | Moligand™ |
Action Type | AGONIST |
Mechanism of action | Agonist of HCA 2 receptor |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
IUPAC Name | 5-butyl-1H-pyrazole-3-carboxylic acid |
---|---|
INCHI | InChI=1S/C8H12N2O2/c1-2-3-4-6-5-7(8(11)12)10-9-6/h5H,2-4H2,1H3,(H,9,10)(H,11,12) |
InChi Key | ZJTXSGLJNBAMJS-UHFFFAOYSA-N |
Canonical SMILES | CCCCC1=CC(=NN1)C(=O)O |
Isomeric SMILES | CCCCC1=CC(=NN1)C(=O)O |
Alternate CAS | 92933-48-7 |
PubChem CID | 6485181 |
MeSH Entry Terms | LUF6283 |
Molecular Weight | 168.19 |
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
L2315113 | Certificate of Analysis | Dec 02, 2023 | L287351 |
L2315114 | Certificate of Analysis | Dec 02, 2023 | L287351 |
L2315115 | Certificate of Analysis | Dec 02, 2023 | L287351 |
L2315116 | Certificate of Analysis | Dec 02, 2023 | L287351 |
L2315117 | Certificate of Analysis | Dec 02, 2023 | L287351 |
L2315118 | Certificate of Analysis | Dec 02, 2023 | L287351 |
L2315119 | Certificate of Analysis | Dec 02, 2023 | L287351 |
L2315120 | Certificate of Analysis | Dec 02, 2023 | L287351 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 16.82, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 16.82, Max Conc. mM: 100 |
---|---|
Sensitivity | Moisture sensitive |
Signal | Warning |
---|---|
Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation |
Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. |